INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 301,923 Value ($000) $39,830 Avg Close — Range —
Q4 2024
Shares 45,212 Value ($000) $3,776 Avg Close — Range —
Q2 2024
Shares 10,364 Value ($000) $710 Avg Close — Range —
Q1 2024
Shares 2,912 Value ($000) $202 Avg Close — Range —
Q3 2023
Shares 130,342 Value ($000) $6,790 Avg Close — Range —
Q2 2023
Shares 94,761 Value ($000) $6,000 Avg Close — Range —
Q1 2023
Shares 85,739 Value ($000) $4,643 Avg Close — Range —
Q4 2022
Shares 75,841 Value ($000) $4,014 Avg Close — Range —
Q3 2022
Shares 69,356 Value ($000) $3,227 Avg Close — Range —
Q2 2022
Shares 104,036 Value ($000) $5,938 Avg Close — Range —
Q1 2022
Shares 176,801 Value ($000) $10,818 Avg Close — Range —
Q4 2021
Shares 93,600 Value ($000) $4,899 Avg Close — Range —
Q3 2021
Shares 96,440 Value ($000) $3,595 Avg Close — Range —
Q2 2021
Shares 87,817 Value ($000) $3,585 Avg Close — Range —
Q1 2021
Shares 67,457 Value ($000) $2,289 Avg Close — Range —
Q4 2020
Shares 67,457 Value ($000) $2,145 Avg Close — Range —
Q3 2019
Shares 118,091 Value ($000) $882 Avg Close — Range —